Statistically Designed Enzymatic Hydrolysis for Optimized Production of Icariside II as a Novel Melanogenesis Inhibitor

  • Park, Jun-Seong (Skin Research Institute, Amorepacific R&D Center) ;
  • Park, Hye-Yoon (Skin Research Institute, Amorepacific R&D Center) ;
  • Rho, Ho-Sik (Skin Research Institute, Amorepacific R&D Center) ;
  • Ahn, Soo-Mi (Skin Research Institute, Amorepacific R&D Center) ;
  • Kim, Duck-Hee (Skin Research Institute, Amorepacific R&D Center) ;
  • Chang, Ih-Seop (Skin Research Institute, Amorepacific R&D Center)
  • 발행 : 2008.01.31

초록

Three kinds of prenylated flavonols, icariside I, icariside II, and icaritin, were isolated from an icariin hydrolysate and their effects on melanogenesis evaluated based on mushroom tyrosinase inhibition and quantifying the melanin contents in melanocytes. Although none of the compounds had an effect on tyrosinase activity, icariside II and icaritin both effectively inhibited the melanin contents with an $IC_{50}$ of 10.53 and $11.13{\mu}M$, respectively. Whereas icariside II was obtained from a reaction with ${\beta}$-glucosidase and cellulase, the icariin was not completely converted into icariside II. Thus, for the high-purity production of icariside II, the reaction was optimized using the response surface methodology, where an enzyme concentration of 5.0mg/ml, pH 7, $37.5^{\circ}C$, and 8 h reaction time were selected as the central conditions for the central composite design (CCD) for the enzymatic hydrolysis of icariin into icariside II using cellulase. Empirical models were developed to describe the relationships between the operating factors and the response (icariside II yield). A statistical analysis indicated that all four factors had a significant effect (p<0.01) on the icariside II production. The coefficient of determination $(R^2)$ was good for the model (0.9853), and the optimum production conditions for icariside II was an enzyme concentration of 7.5mg/ml, pH 5, $50^{\circ}C$, and 12 h reaction time. A good agreement between the predicted and experimental data under the designed optimal conditions confirmed the usefulness of the model. A laboratory pilot scale was also successful.

키워드

참고문헌

  1. Aristidou, A. and M. Penttila. 2000. Metabolic engineering applications to renewable resource utilization. Curr. Opin. Biotechnol. 11: 187-198 https://doi.org/10.1016/S0958-1669(00)00085-9
  2. Choi, H. J., S. M. Anh, B. G. Lee, I. S. Chang, and J. S. Hwang. 2005. Inhibition of skin pigmentation by an extract of lepidium apetalum and its possible implications in IL-6 mediated signaling. Pigment Cell Res. 18: 439-446
  3. Curto, E. V., C. Kwong, H. Hermersdorfer, H. Glatt, C. Santis, V. Virador, V. J. Hearing Jr., and T. P. Dooley. 1999. Inhibition of mammalian melanocyte tyrosinase: In vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. Biochem. Pharmacol. 57: 663-672 https://doi.org/10.1016/S0006-2952(98)00340-2
  4. Dooley, T. P., R. C. Gadwood, K. Kilgore, and L. M. Thomasco. 1994. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol. 7: 188-200 https://doi.org/10.1159/000211294
  5. Huang, K. H. and C. C. Akoh. 1996. Optimization and scale-up of enzymatic synthesis of structured lipids using RSM. J. Food Sci. 61: 137-141 https://doi.org/10.1111/j.1365-2621.1996.tb14743.x
  6. Kim, D. H., J. S. Hwang, H. S. Baek, K. J. Kim, B. G. Lee, I. S. Chang, H. H. Kang, and O. S. Lee. 2003. Development of 5-[(3-aminopropyl)phosphinooxy]-2-(hydroxymethyl)-4H-pyran- 4-one as a novel whitening agent. Chem. Pharm. Bull. 51: 113-116 https://doi.org/10.1248/cpb.51.113
  7. Lee, N. K., K. H. Son, H. W. Chang, S. S. Kang, H. Park, M. Y. Heo, and H. P. Kim. 2004. Prenylated flavonoids as tyrosinase inhibitors. Arch. Pharm. Res. 27: 1132-1135 https://doi.org/10.1007/BF02975118
  8. Lee, C. Y., K. H. Kim, S. Y. Hur, J. H. Heo, M. H. Choi, S. K. Rhee, and C. H. Kim. 2006. Enzymatic synthesis of ascorbic acid fructoside by transfructosylation using levan fructotransferase. J. Microbiol. Biotechnol. 16: 64-67
  9. Lee, Y. J., B. G. Kim, Y. H. Park, Y. H. Lim, H. G. Hur, and J. H. Ahn. 2006. Biotransformation of flavonoids with O-methyltransferase from Bacillus cereus. J. Microbiol. Biotechnol. 16: 1090-1096
  10. Lee, B. H., H. J. You, M. S. Park, B. Kwon, and G. E. Ji. 2006. Transformation of the glycosides from food materials by probiotics and food microorganisms. J. Microbiol. Biotechnol. 16: 497-504
  11. Mizuo, M., H. Sakura, S. Noriyo, I. Munekazu, T. Tohiyuki, X. S. Liu, and Z. D. Min. 1987. Flavonol glycosides from Epimedium sagittatum. Phytochemistry 26: 861-863 https://doi.org/10.1016/S0031-9422(00)84809-8
  12. Pomerantz, S. H. 1963. Separation, purification, and properties of two tyrosinases from hamster melanoma. J. Biol. Chem. 238: 2351-2357
  13. Roy, D., L. Daoudi, and A. Azaola. 2002. Optimization of galacto-oligosaccharide production by Bifidobacterium infantis RW-8120 using response surface methodology. J. Ind. Microbiol. Biotechnol. 29: 281-285 https://doi.org/10.1038/sj.jim.7000319
  14. Shieh, C. J., C. C. Akoh, and P. E. Koehler. 1995. Four-factor response surface optimization of the enzymatic modification of triolin to structured lipids. J. Am. Oil Chem. Soc. 72: 619-623 https://doi.org/10.1007/BF02635645
  15. Toshio, F. and N. Taro. 1988. Seven prenylated flavonol glycosides from two Epimedium species. Phytochemistry 27: 259-266 https://doi.org/10.1016/0031-9422(88)80627-7
  16. Yeshi, L. and L. Yonglong. 1990. Flavonol glycosides from Epimedium wushanense. Phytochemistry 29: 3311-3314 https://doi.org/10.1016/0031-9422(90)80206-V
  17. Zheung, G. and S. Yan. 2004. Solvent-free enzymatic synthesis of 1,3-diconjugated linoleoyl glycerol optimized by response surface methodology. Biotechnol. Prog. 20: 619-622 https://doi.org/10.1021/bp034212m